TY  - GEN
AU  - Afdhal,Nezam
AU  - Reddy,K Rajender
AU  - Nelson,David R
AU  - Lawitz,Eric
AU  - Gordon,Stuart C
AU  - Schiff,Eugene
AU  - Nahass,Ronald
AU  - Ghalib,Reem
AU  - Gitlin,Norman
AU  - Herring,Robert
AU  - Lalezari,Jacob
AU  - Younes,Ziad H
AU  - Pockros,Paul J
AU  - Di Bisceglie,Adrian M
AU  - Arora,Sanjeev
AU  - Subramanian,G Mani
AU  - Zhu,Yanni
AU  - Dvory-Sobol,Hadas
AU  - Yang,Jenny C
AU  - Pang,Phillip S
AU  - Symonds,William T
AU  - McHutchison,John G
AU  - Muir,Andrew J
AU  - Sulkowski,Mark
AU  - Kwo,Paul
TI  - Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
SN  - 1533-4406
PY  - 2014///0506
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - adverse effects
KW  - Benzimidazoles
KW  - administration & dosage
KW  - Drug Combinations
KW  - Female
KW  - Fluorenes
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Nucleotidyltransferases
KW  - antagonists & inhibitors
KW  - RNA-Dependent RNA Polymerase
KW  - Sofosbuvir
KW  - Uridine Monophosphate
KW  - Viral Load
KW  - Viral Nonstructural Proteins
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1316366
ER  -